Compare IOT & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IOT | DGX |
|---|---|---|
| Founded | 2015 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.8B | 20.5B |
| IPO Year | 2021 | 1996 |
| Metric | IOT | DGX |
|---|---|---|
| Price | $45.48 | $182.89 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 15 |
| Target Price | $49.90 | ★ $194.07 |
| AVG Volume (30 Days) | ★ 5.4M | 1.2M |
| Earning Date | 12-04-2025 | 10-21-2025 |
| Dividend Yield | N/A | ★ 1.75% |
| EPS Growth | N/A | ★ 14.49 |
| EPS | N/A | ★ 8.51 |
| Revenue | $1,520,629,000.00 | ★ $10,850,000,000.00 |
| Revenue This Year | $27.68 | $12.37 |
| Revenue Next Year | $20.63 | $3.52 |
| P/E Ratio | ★ N/A | $21.44 |
| Revenue Growth | ★ 28.96 | 13.74 |
| 52 Week Low | $31.40 | $148.70 |
| 52 Week High | $61.90 | $197.55 |
| Indicator | IOT | DGX |
|---|---|---|
| Relative Strength Index (RSI) | 73.46 | 44.87 |
| Support Level | $36.88 | $184.18 |
| Resistance Level | $38.47 | $185.12 |
| Average True Range (ATR) | 1.85 | 3.22 |
| MACD | 0.72 | -0.78 |
| Stochastic Oscillator | 82.90 | 3.85 |
Samsara Inc provides an end-to-end solution for operations. The company's Connected Operations Platform consolidates data from its IoT devices and a growing ecosystem of connected assets and third-party systems, and makes it easy for organizations to access, analyze, and act on data insights using its cloud dashboard, custom alerts and reports, mobile apps, and workflows.. The company derives almost all of its revenue from subscription services. Geographically, it derives a majority of its revenue from the United States. The company's customers ranges from small and medium-sized businesses to state and local governments.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.